Biotech Firm OKYO Pharma Closes US$2.5 Million IPO

Biotech firm OKYO Pharma Limited (Nasdaq: OKYO) closed on Thursday its initial public offering on the Nasdaq Capital Market. The firm was able to raise approximately US$2.5 million in its debut on the big board.

The offering consisted of 625,000 American depository shares at US$4.00 per share. The company’s shares are trading under the symbol “OKYO”.

Proceeds of the offering are intended for advancing the firm’s drug candidate OK-101 to filing an investigative new drug application, funding the drug’s phase 2 clinical trial, and for working capital and other general corporate purposes.

ThinkEquity acted as the sole bookrunner for the said offering.

The London-based life sciences company is focused on treating patients suffering from inflammatory eye diseases and ocular pain. It is presently developing its lead preclinical product candidate OK-101 to treat dry-eye disease.

OKYO Pharma last traded at US$3.00 on the Nasdaq.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Goliath Resources Hits 10.60 g/t Gold Over 22.82 Metres, Highest Grade Results In Third Distinct Rock Package At Surebet Discovery

Four Countries Control the Fertilizer That Feeds the World | Sage Potash

$10,000 Gold Is Just A Question of Time | Florian Grummes

Recommended

ESGold Outlines $24.3 Million NPV For Tailings Reprocessing Project

First Majestic Encounters 711 g/t Silver Equivalent Over 8.0 Metres In Ongoing Exploration At Los Gatos

Related News

Eye Care Firm Bausch + Lomb Seeks To Raise $630 Million In NYSE, TSX IPOs

Bausch Health Companies (NYSE/TSX: BHC) subsidiary, eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO)...

Friday, May 6, 2022, 02:24:00 PM

Birkenstock Files For $8 Billion IPO

Birkenstock, the renowned German footwear company, took a significant step towards going public on Tuesday....

Wednesday, September 13, 2023, 10:36:00 AM

Railroad SPAC Integrated Rail and Resources Acquisition Prices US$200 Million IPO

Special purpose acquisition company Integrated Rail and Resources Acquisition Corp. (NYSE: IRRXU) went public today...

Friday, November 12, 2021, 02:10:00 PM

Beverage Firm Westrock Coffee To Be Taken Public In A US$1.1 Billion SPAC Merger

Beverage brand Westrock Coffee Holdings entered into a definitive business combination agreement with special purpose...

Wednesday, April 6, 2022, 02:26:00 PM

Semrush: The IPO Deep Dive

Semrush (NYSE: SEMR) is an online platform that offers a suite of tools to companies,...

Thursday, March 25, 2021, 12:31:00 PM